Inhibition of dipeptidyl peptidase-4: The mechanisms of action and clinical use of vildagliptin for the management of type 2 diabetes

Adrian Vella, Galina Smushkin
2009 Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy  
doi:10.2147/dmso.s4790 fatcat:3hxd6frttffchlf2flfqmcll2y